Literature DB >> 24807717

Novel roles of cytoplasmic ICP0: proteasome-independent functions of the RING finger are required to block interferon-stimulated gene production but not to promote viral replication.

Kathryne E Taylor1, Marianne V Chew2, Ali A Ashkar2, Karen L Mossman3.   

Abstract

The immediate-early protein ICP0 from herpes simplex virus 1 (HSV-1) plays pleiotropic roles in promoting viral lytic replication and reactivation from latency. Most of the known actions of ICP0 occur in the nucleus and are thought to involve the E3 ubiquitin ligase activity of its RING finger domain, which targets proteins for degradation via the proteasome. Although ICP0 translocates to the cytoplasm as the infection progresses, little is known about its activities in this location. Here, we show that cytoplasmic ICP0 has two distinct functions. In primary cell cultures and in an intravaginal mouse model, cytoplasmic ICP0 promotes viral replication in the absence of an intact RING finger domain. Additionally, ICP0 blocks the activation of interferon regulatory factor 3 (IRF3), a key transcription factor of the innate antiviral response, in a mechanism that requires the RING finger domain but not the proteasome. To our knowledge, this is the first observation of a proteasome-independent function of the RING finger domain of ICP0. Collectively, these results underscore the importance of cytoplasm-localized ICP0 and the diverse nature of its activities. Importance: Despite ICP0 being a well-studied viral protein, the significance of its cytoplasmic localization has been largely overlooked. This is, in part, because common experimental manipulations result in the restriction of ICP0 to the nucleus. By overcoming this constraint, we both further characterize the ability of cytoplasmic ICP0 to inhibit antiviral signaling and show that ICP0 at this site has unexpected activities in promoting viral replication. This demonstrates the importance of considering location when analyzing protein function and adds a new perspective to our understanding of this multifaceted protein.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24807717      PMCID: PMC4097794          DOI: 10.1128/JVI.00944-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  112 in total

1.  The two functions of herpes simplex virus 1 ICP0, inhibition of silencing by the CoREST/REST/HDAC complex and degradation of PML, are executed in tandem.

Authors:  Haidong Gu; Bernard Roizman
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

2.  DUBA: a deubiquitinase that regulates type I interferon production.

Authors:  Nobuhiko Kayagaki; Qui Phung; Salina Chan; Ruchir Chaudhari; Casey Quan; Karen M O'Rourke; Michael Eby; Eric Pietras; Genhong Cheng; J Fernando Bazan; Zemin Zhang; David Arnott; Vishva M Dixit
Journal:  Science       Date:  2007-11-08       Impact factor: 47.728

Review 3.  Genital herpes.

Authors:  Rachna Gupta; Terri Warren; Anna Wald
Journal:  Lancet       Date:  2007-12-22       Impact factor: 79.321

4.  Herpes simplex virus type 1 immediate-early protein ICP27 is required for efficient incorporation of ICP0 and ICP4 into virions.

Authors:  Lenka Sedlackova; Stephen A Rice
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

5.  STAT-1- and IRF-3-dependent pathways are not essential for repression of ICP0-null mutant herpes simplex virus type 1 in human fibroblasts.

Authors:  Roger D Everett; Dan F Young; Rick E Randall; Anne Orr
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

Review 6.  Atypical ubiquitin chains: new molecular signals. 'Protein Modifications: Beyond the Usual Suspects' review series.

Authors:  Fumiyo Ikeda; Ivan Dikic
Journal:  EMBO Rep       Date:  2008-06       Impact factor: 8.807

7.  TRAF6 and the three C-terminal lysine sites on IRF7 are required for its ubiquitination-mediated activation by the tumor necrosis factor receptor family member latent membrane protein 1.

Authors:  Shunbin Ning; Alex D Campos; Bryant G Darnay; Gretchen L Bentz; Joseph S Pagano
Journal:  Mol Cell Biol       Date:  2008-08-18       Impact factor: 4.272

8.  Histone modifications associated with herpes simplex virus type 1 genomes during quiescence and following ICP0-mediated de-repression.

Authors:  Heather M Coleman; Viv Connor; Zara S C Cheng; Finn Grey; Chris M Preston; Stacey Efstathiou
Journal:  J Gen Virol       Date:  2008-01       Impact factor: 3.891

9.  Replication of ICP0-null mutant herpes simplex virus type 1 is restricted by both PML and Sp100.

Authors:  Roger D Everett; Carlos Parada; Philippe Gripon; Hüseyin Sirma; Anne Orr
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

10.  Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo.

Authors:  D A Leib; T E Harrison; K M Laslo; M A Machalek; N J Moorman; H W Virgin
Journal:  J Exp Med       Date:  1999-02-15       Impact factor: 14.307

View more
  16 in total

1.  The Us3 Protein of Herpes Simplex Virus 1 Inhibits T Cell Signaling by Confining Linker for Activation of T Cells (LAT) Activation via TRAF6 Protein.

Authors:  Yin Yang; Songfang Wu; Yu Wang; Shuang Pan; Bei Lan; Yaohui Liu; Liming Zhang; Qianli Leng; Da Chen; Cuizhu Zhang; Bin He; Youjia Cao
Journal:  J Biol Chem       Date:  2015-04-23       Impact factor: 5.157

2.  Defining the Role of Stress Granules in Innate Immune Suppression by the Herpes Simplex Virus 1 Endoribonuclease VHS.

Authors:  Hannah M Burgess; Ian Mohr
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

3.  Cellular Protein WDR11 Interacts with Specific Herpes Simplex Virus Proteins at the trans-Golgi Network To Promote Virus Replication.

Authors:  Kathryne E Taylor; Karen L Mossman
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

Review 4.  Innate Immune Mechanisms and Herpes Simplex Virus Infection and Disease.

Authors:  Evelyn A Kurt-Jones; Megan H Orzalli; David M Knipe
Journal:  Adv Anat Embryol Cell Biol       Date:  2017       Impact factor: 1.231

5.  Characterization of Elements Regulating the Nuclear-to-Cytoplasmic Translocation of ICP0 in Late Herpes Simplex Virus 1 Infection.

Authors:  Subodh Kumar Samrat; Binh L Ha; Yi Zheng; Haidong Gu
Journal:  J Virol       Date:  2018-01-02       Impact factor: 5.103

Review 6.  A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation.

Authors:  Peter G E Kennedy; Joel Rovnak; Hussain Badani; Randall J Cohrs
Journal:  J Gen Virol       Date:  2015-03-20       Impact factor: 3.891

7.  Cbl E3 Ligase Mediates the Removal of Nectin-1 from the Surface of Herpes Simplex Virus 1-Infected Cells.

Authors:  Thibaut Deschamps; Christos Dogrammatzis; Ranajoy Mullick; Maria Kalamvoki
Journal:  J Virol       Date:  2017-05-26       Impact factor: 5.103

8.  Impaired STING Pathway in Human Osteosarcoma U2OS Cells Contributes to the Growth of ICP0-Null Mutant Herpes Simplex Virus.

Authors:  Thibaut Deschamps; Maria Kalamvoki
Journal:  J Virol       Date:  2017-04-13       Impact factor: 5.103

9.  Neurons versus herpes simplex virus: the innate immune interactions that contribute to a host-pathogen standoff.

Authors:  Pamela C Rosato; David A Leib
Journal:  Future Virol       Date:  2015-06       Impact factor: 1.831

10.  Widely Used Herpes Simplex Virus 1 ICP0 Deletion Mutant Strain dl1403 and Its Derivative Viruses Do Not Express Glycoprotein C Due to a Secondary Mutation in the gC Gene.

Authors:  Cristina W Cunha; Kathryne E Taylor; Suzanne M Pritchard; Mark G Delboy; Tri Komala Sari; Hector C Aguilar; Karen L Mossman; Anthony V Nicola
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.